Cargando…

Persistent COVID-19 Symptoms Minimally Impact the Development of SARS-CoV-2-Specific T Cell Immunity

SARS-CoV-2 represents an unprecedented public health challenge. While the majority of SARS-CoV-2-infected individuals with mild-to-moderate COVID-19 resolve their infection with few complications, some individuals experience prolonged symptoms lasting for weeks after initial diagnosis. Persistent vi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fang, Hengsheng, Wegman, Adam D., Ripich, Kianna, Friberg, Heather, Currier, Jeffrey R., Thomas, Stephen J., Endy, Timothy P., Waickman, Adam T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155927/ https://www.ncbi.nlm.nih.gov/pubmed/34063463 http://dx.doi.org/10.3390/v13050916

Ejemplares similares

Monomeric IgA Antagonizes IgG-Mediated Enhancement of DENV Infection
por: Wegman, Adam D., et al.
Publicado: (2021)

Assessing the Diversity and Stability of Cellular Immunity Generated in Response to the Candidate Live-Attenuated Dengue Virus Vaccine TAK-003
por: Waickman, Adam T., et al.
Publicado: (2019)

Simultaneous analysis of antigen‐specific B and T cells after SARS‐CoV‐2 infection and vaccination
por: Newell, Krista L., et al.
Publicado: (2022)

mRNA-1273 vaccination protects against SARS-CoV-2–elicited lung inflammation in nonhuman primates
por: Waickman, Adam T., et al.
Publicado: (2022)

Stochastic Model of the Adaptive Immune Response Predicts Disease Severity and Captures Enhanced Cross-Reactivity in Natural Dengue Infections
por: Nguyen, Hung D., et al.
Publicado: (2021)

Inflammation, immunity, and antigen persistence in post-acute sequelae of SARS-CoV-2 infection
por: Newell, Krista L, et al.
Publicado: (2022)

Systemic Cancer Therapy Does Not Significantly Impact Early Vaccine-Elicited SARS-CoV-2 Immunity in Patients with Solid Tumors
por: Waickman, Adam T., et al.
Publicado: (2022)

Temporally integrated single cell RNA sequencing analysis of PBMC from experimental and natural primary human DENV-1 infections
por: Waickman, Adam T., et al.
Publicado: (2021)

Dissecting the heterogeneity of DENV vaccine-elicited cellular immunity using single-cell RNA sequencing and metabolic profiling
por: Waickman, Adam T., et al.
Publicado: (2019)

Longitudinal Analysis of Dengue Virus–Specific Memory T Cell Responses and Their Association With Clinical Outcome in Subsequent DENV Infection
por: Sanchez-Vargas, Luis Alberto, et al.
Publicado: (2021)

Mobilization and Activation of the Innate Immune Response to Dengue Virus
por: King, Christine A., et al.
Publicado: (2020)

DENV-specific IgA contributes protective and non-pathologic function during antibody-dependent enhancement of DENV infection
por: Wegman, Adam D., et al.
Publicado: (2023)

Analysis of cell-associated DENV RNA by oligo(dT) primed 5’ capture scRNAseq
por: Sanborn, Mark A., et al.
Publicado: (2020)

Protective versus pathologic pre-exposure cytokine profiles in dengue virus infection
por: Friberg, Heather, et al.
Publicado: (2018)

Transcriptional and clonal characterization of B cell plasmablast diversity following primary and secondary natural DENV infection
por: Waickman, Adam T., et al.
Publicado: (2020)

Investigating the Relationship between Vitamin D and Persistent Symptoms Following SARS-CoV-2 Infection
por: Townsend, Liam, et al.
Publicado: (2021)

Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults
por: Wagner, Angelika, et al.
Publicado: (2021)

782 PERSISTENT GASTROINTESTINAL SYMPTOMS AND CHRONIC FATIGUE AFTER SARS-COV-2 INFECTION.
por: Noviello, Daniele, et al.
Publicado: (2021)

Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration
por: Newell, Krista L., et al.
Publicado: (2021)

Persistence of SARS-CoV-2-specific antibodies in COVID-19 patients
por: Wang, Yanan, et al.
Publicado: (2021)

Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques
por: McCracken, Michael K., et al.
Publicado: (2021)

Persistence of SARS-CoV-2-Specific Antibodies for 13 Months after Infection
por: Kučinskaitė-Kodzė, Indrė, et al.
Publicado: (2021)

Minimal system for assembly of SARS-CoV-2 virus like particles
por: Swann, Heather, et al.
Publicado: (2020)

The ontogeny of memory persistence and specificity
por: Ramsaran, Adam I., et al.
Publicado: (2018)

One‐year persistent symptoms and functional impairment in SARS‐CoV‐2 positive and negative individuals
por: Nehme, Mayssam, et al.
Publicado: (2022)

Symptômes respiratoires persistant après une infection à SARS-CoV-2 : quelques repères
Publicado: (2022)

PREDICTORS OF PERSISTENT SYMPTOMS AFTER MRNA SARS-COV-2 VACCINE-RELATED MYOCARDITIS (MYOVACC REGISTRY)
por: Schroth, Daniel, et al.
Publicado: (2023)

SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses
por: Vibholm, Line K, et al.
Publicado: (2021)

Olfactory dysfunction in SARS-CoV-2 infection: Focus on odorant specificity and chronic persistence
por: Rebholz, H., et al.
Publicado: (2021)

Clonal diversity predicts persistence of SARS-CoV-2 epitope-specific T-cell response
por: Zornikova, Ksenia V., et al.
Publicado: (2022)

SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptoms
por: Fröberg, Janeri, et al.
Publicado: (2021)

Comparison of Persistent Symptoms After COVID-19 and Other Non-SARS-CoV-2 Infections in Children
por: Roge, Ieva, et al.
Publicado: (2021)

More Than 100 Persistent Symptoms of SARS-CoV-2 (Long COVID): A Scoping Review
por: Hayes, Lawrence D., et al.
Publicado: (2021)

Persistent symptoms after SARS-CoV-2 infection: Long-term implications for health and quality of life
por: So, Mike K.P., et al.
Publicado: (2022)

Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection
por: Captur, Gabriella, et al.
Publicado: (2022)

Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity
por: Altmann, Daniel M., et al.
Publicado: (2023)

Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection
por: Richard, Stephanie A., et al.
Publicado: (2023)

Acute Limb Ischemia in Minimally Symptomatic SARS-CoV-2 Infection
por: Maurera, Annabella H., et al.
Publicado: (2020)

Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
por: Choi, Bina, et al.
Publicado: (2020)

No Evidence of SARS-CoV-2 Seminal Shedding Despite SARS-CoV-2 Persistence in the Upper Respiratory Tract
por: Rawlings, Stephen A, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j46tcmc8s6nn8j7c4g7c899s3g